Qumra Capital
VC Fund
Tel Aviv, Israel
Qumra Capital is an Israeli Venture Capital fund that focuses on the Israeli late-stage market and technology-driven companies.They focus on highly analytical, data-driven companies that can successfully scale to the power of enterprise and invest in rapidly growing companies with a proven market fit.Qumra Capital was founded in 2012 by BoazDinte, Erez Shachar, and Sivan Shamri Dahan.
- Total investments:
- 47
- Last investment:
- Lead investor:
- 51%
- Fund size:
- $260M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Qumra Capital invests in
Stages Qumra Capital invests in
Countries Qumra Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Investment Focus
Industry
- Software 9 (19%)
- Artificial Intelligence 8 (17%)
- Health Care 5 (11%)
- Cyber Security 5 (11%)
- Machine Learning 5 (11%)
Stage
- Series C 14 (30%)
- Series D 12 (26%)
- Series B 8 (17%)
- Series E 4 (9%)
- Venture - Series Unknown 3 (6%)
Country
- United States 16 (34%)
- Israel 14 (30%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Boaz Dinte
Co-founder & Managing General Partner
|
Co-founder & Managing General Partner | Total investments: 24 | Find email | |
Erez Shachar
Co-founder & Managing Partner
|
Co-founder & Managing Partner | Total investments: 16 | Find email | |
Noa Korman
Principal
|
Principal | Total investments: 0 | Find email | |
Sharon Barzik-Cohen
Partner and Chief Financial Officer
|
Partner and Chief Financial Officer | Total investments: 0 | Find email | |
Yael Paz
VP Business Development
|
VP Business Development | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform enables maximum control of construction processes at minimal effort. The solution turns every site walk into valuable process data that can immediately be used for gaining full control of a certain project. | $130M / Series E / Sep 14, 2026 | ||
| Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms ofAction™.It was founded in 2022 and is located in Ramat Gan, Tel Aviv. | $36M / Series A / Aug 12, 2026 | ||
| Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services. | $45M / Series B / Aug 04, 2026 | ||
| Zenity is the first and only governance and security platform for low-code/no-code applications. It creates a win-win environment where IT and information security can give business and pro developers the independence they want to move the business forward while retaining full visibility and control. | $115M / Series C / Aug 03, 2026 | ||
| TytoCare is a mobile-health platform and device, allowing anyone to perform self physical examination and remote diagnosis.Tyto Care has three telehealth products: the TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote point-of-care locations. All solutions are designed to replicate a facetious clinician visit andinclude a modular examination tool for examining the heart, lungs, skin, throat, ears, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use. TytoCare was founded by Dedi Gilad, Ofer Tzadik in 2012 with a vision to put health in the hands of the consumer. | $25M / Venture - Series Unknown / Jul 15, 2026 | ||
| CodiumAI is leveraging the power of artificial and human intelligence to create a new code integrity paradigm. CodiumAI enables developers to build faster and with fewer bugs. | $70M / Series B / Mar 30, 2026 | ||
| DataRails is a financial planning and analysis platform that automates financial reporting and planning, while enabling finance teams to continue benefiting from the familiar spreadsheets and financial models of Excel. Automating these time-consuming manual processes paves the way for finance teams to spend more time analyzing data and less timegathering it. And it empowers them to answer essential strategic questions like what their organization can do to increase revenue and reduce expenses. | $70M / Series C / Jan 21, 2026 | ||
| Clanz Technologies offers an audio-based system designed to support security in human interactions. The system works by connecting to devices that record audio. It analyzes audio data to find unusual sounds or patterns that may indicate incidents. When an anomaly is detected, the system sends alerts in real time. The service also providesinformation about conditions that can affect care quality, such as stress levels or lack of training. It can be used in places where monitoring human interaction is important for safety. The company offers a demo for organizations that want to use the system. | $45M / Series C / Oct 09, 2025 | ||
| Blocks.diy offers an AI-native platform that allows any professional to create custom work tools and clever AI agents via simple communication. It was created by monday.com alumni with vast experience in workflow optimization. It connects with existing business tools and data to build personalized productivity solutions that help non-technicalindividuals perform better and offer optimal results to their clients and partners. | $10M / Seed / Sep 10, 2025 | ||
| Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform enables maximum control of construction processes at minimal effort. The solution turns every site walk into valuable process data that can immediately be used for gaining full control of a certain project. | $45M / Series D / May 29, 2025 | ||
| See all 47 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Qumra Capital invest in?
Qumra Capital invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Series C and Series D stage. Most of the 47 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Qumra Capital?
Public channels for Qumra Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Qumra Capital?
The team at Qumra Capital includes Boaz Dinte (Co-founder & Managing General Partner), Erez Shachar (Co-founder & Managing Partner) and Noa Korman (Principal), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
